Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 388

The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.

Melatonin for the prevention and treatment of cancer

Open access
Li, Ya, Li, Sha, Zhou, Yue, Meng, Xiao, Zhang, Jiao-Jiao, Xu, Dong-Ping, Li, Hua-Bin·2017·Oncotarget

Abstract

// Ya Li 1 , Sha Li 2,* , Yue Zhou 1 , Xiao Meng 1 , Jiao-Jiao Zhang 1 , Dong-Ping Xu 1 and Hua-Bin Li 1,3,* 1 Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, China 2 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China 3 South China Sea Bioresource Exploitation and Utilization Collaborative Innovation Center, Sun Yat-Sen University, Guangzhou, China Correspondence to: Hua-Bin Li, email: // Sha Li, email: // Keywords : melatonin; anticancer; mechanisms of action; receptor; apoptosis Received : January 20, 2017 Accepted : March 09, 2017 Published : March 18, 2017 Abstract The epidemiological studies have indicated a possible oncostatic property of melatonin on different types of tumors. Besides, experimental studies have documented that melatonin could exert growth inhibition on some human tumor cells in vitro and in animal models. The underlying mechanisms include antioxidant activity, modulation of melatonin receptors MT1 and MT2, stimulation of apoptosis, regulation of pro-survival signaling and tumor metabolism, inhibition on angiogenesis, metastasis, and induction of epigenetic alteration. Melatonin could also be utilized as adjuvant of cancer therapies, through reinforcing the therapeutic effects and reducing the side effects of chemotherapies or radiation. Melatonin could be an excellent candidate for the prevention and treatment of several cancers, such as breast cancer, prostate cancer, gastric cancer and colorectal cancer. This review summarized the anticancer efficacy of melatonin, based on the results of epidemiological,experimental and clinical studies, and special attention was paid to the mechanisms of action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.16379

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 175 references

Cited by

See all 388

Metadata

Authors
Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J.-J., Xu, D.-P., & Li, H.-B.
Venue
Oncotarget
Published
2017-03-18
Volume
8
Issue
24
Pages
39896-39921
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2597174991
Cited by
388
References
175
FWCI
16.40
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melatonin for the prevention and treatment of cancer. https://app.cochat.ai/papers/10.18632/oncotarget.16379
The paper
Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J.-J., Xu, D.-P., & Li, H.-B. (2017). Melatonin for the prevention and treatment of cancer. Oncotarget. https://doi.org/10.18632/oncotarget.16379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.